Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

565 Views

Poster Session: Clinical Trials

234 - Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

GC

Grace L. Chen, MD, MPH

N/A
Moderna, Inc.
Cambridge, Massachusetts, United States

Co-Author(s)

RM

Runa Mithani, PharmD

Moderna, Inc.
Cambridge, Massachusetts, United States
AK

Archana Kapoor, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
SL

Sophia Lu, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
LE

Laila El Asmar, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
CP

Catherine A. Panozzo, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
CS

Christine A. Shaw, PhD

Senior Director
Moderna, Inc.
Cambridge, Massachusetts, United States
SS

Sonia K. Stoszek, PhD

Moderna, Inc.
Cambridge, Massachusetts, United States
AA

Allison August, MD

Moderna, Inc.
Cambridge, Massachusetts, United States